Quinn Opportunity Partners’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,000	Closed	-$255K	–	381
2025 Q1	$255K	Buy	+25,000	New	+$255K	0.02%	305